Content By Peter Marks

Peter Marks’s picture

By: Peter Marks

Peter Marks’s picture

By: Peter Marks

Part of the vision of the Center for Biologics Evaluation and Research (CBER) is to strengthen the center as the preeminent regulatory organization for biologics. One way CBER is achieving this is through the work of the Office of Compliance and Biologics Quality (OCBQ) and the Office of Vaccines Research and Review (OVRR).